Using mesenchymal stem cells for the treatment of non-obstructive azoospermia


DOI: https://dx.doi.org/10.18565/urology.2020.4.119-123

U. Zhanbyrbekuly, A. Tamadon, Sh.K. Akhnazarov, M.A. Suleiman, E.I. Aynayev, U.S. Zhaparov, R.A. Zhankina, A.K. Ibragimov, A. Yessenuly

1) Department of Urology and Andrology, NCJSC «Medical university of Astana», Nur-Sultan, Kazakhstan; 2) Shiraz University of Medical Sciences, Shiraz, Iran; 3) NCJSC «Medical University of Astana», Nur-Sultan, Kazakhstan, 4) ECOMED CLINIC, Nur-Sultan, Kazakhstan.
Approximately 15% of couples of reproductive age are infertile. Among patients with infertility, nearly 10–15% have azoospermia. The current treatment methods of non-obstructive azoospermia, in particular the use of mesenchymal stem cells, and the comparative analysis of the cost-effectiveness of different methods are discussed in the article.

About the Autors


Corresponding author: U. Zhanbyrbekuly – Ph.D., associate professor, Head of Department of Urology, NCJC "Medical University of Astana"; e-mail: ulanbek.amu@gmail.com


Similar Articles


Бионика Медиа